Evidence map›Paper›PMID 33344280›Full record

ArticleAutopsy & case reports2020

Hepatoid adenocarcinoma of the lung mimicking metastatic hepatocellular carcinoma.

Yu Miyama, Takeshi Fujii, Kyoko Murase, Hisashi Takaya, Fukuo Kondo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Autopsy & case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Hepatoid adenocarcinoma of the lung: clinicopathologic and molecular analysis of 17 cases.Virchows Archiv : an international journal of pathology · 2026
    Article
  4. Article
  5. Hepatoid adenocarcinoma of the lung: A case report.World journal of clinical cases · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yu MiyamaThe University of Tokyo, Graduate School of Medicine, Department of Pathology. Tokyo, Japan.ORCID 0000-0001-5901-6961
Takeshi FujiiToranomon Hospital Kajigaya, Department of Pathology. Kawasaki, Japan.ORCID 0000-0001-7237-1183
Kyoko MuraseToranomon Hospital Kajigaya, Department of Respiratory Medicine. Kawasaki, Japan.ORCID 0000-0002-0418-843X
Hisashi TakayaToranomon Hospital Kajigaya, Department of Respiratory Medicine. Kawasaki, Japan.ORCID 0000-0002-0116-4184
Fukuo KondoTeikyo University Hospital, Department of Pathology. Tokyo, Japan.ORCID 0000-0003-0392-3997

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatoid adenocarcinoma of the lung is a rare subtype of lung cancer. We report a case of a metastatic hepatoid adenocarcinoma of the lung with aggressive behavior, including biopsy and autopsy findings. The pulmonary tumors showed features indistinguishable from hepatocellular carcinoma and were diffusely positive for Hepatocyte Paraffin 1.

Indexed as

AdenocarcinomaHepatocellular carcinomaHepatoid carcinomaNon-small cell carcinoma,

Identifiers

PMID33344280
PMCPMC7703083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.